Skip to main content Skip to footer content Disable Carousel Autoplay
Specialty Areas

AST Subcommittee | Antifungal

Performance Standards for Testing and Treatment

Promoting Accurate Testing and Appropriate Reporting

Volunteers for CLSI’s Subcommittee on Antifungal Susceptibility Tests collaborate to develop standards and guidelines that promote accurate antifungal susceptibility testing and appropriate reporting.

Individuals from the following areas join together to pool knowledge, expertise, and viewpoints:

  • Microbiology laboratories
  • Government agencies
  • Health care providers and educators
  • Pharmaceutical and diagnostic microbiology manufacturers

In this way, the interests of the professions, government, and industry remain balanced and aimed at a single common interest—quality medical testing.

Antifungal Subcommittee Structure

Much of the work of the AST Subcommittee is done through Working Groups.
Learn more about CLSI Working Groups
Understand the CLSI Standards Development Process

Antifungal Subcommittee

CLSI thanks these committed volunteers for their valued contributions.

Subcommittee on Antifungal Susceptibility Tests (AFUNG)

  • Barbara D. Alexander, MD, MHS / Member / Duke University Medical Center, United States
  • David Andes, MD / Member / University of Wisconsin - Madison Medical School, United States
  • Esther Babady, PhD, D(ABMM), FIDSA, F(AAM) / Advisor / Memorial Sloan Kettering Cancer Center, United States
  • Shukal Bala / Advisor / FDA CDER, United States
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Advisor / Centers for Disease Control and Prevention, United States
  • Andrew M. Borman, BSc, PhD / Member / Public Health England, United Kingdom
  • Cecilia Carvalhaes / Advisor / bioMérieux, United States
  • Sharon Chen / Advisor, United States
  • Anuradha Chowdhary, MD, PhD / Advisor / Vallabhbhai Patel Chest Institute, India
  • Sharon K. Cullen, BS, RAC / Advisor / Beckman Coulter, Inc. Microbiology Business, United States
  • Ryan Demkowicz, MD / Secretary / West Virginia University Hospital, United States
  • Tanis Dingle, PhD, D(ABMM), FCCM / Member / Alberta Precision Laboratories - Public Health Laboratory, Canada
  • Philippe J. Dufresne, PhD / Chairholder / Institut national de santé publique du Québec, Canada
  • Hari P. Dwivedi, BVSc(DVM), MVSc, PhD / Member / bioMerieux, Inc., United States
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Advisor / London Health Sciences Centre, Canada
  • Guillermo Garcia-Effron, BSc, PhD / Advisor / Universidad nacional del Litoral - Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Argentina
  • Mahmoud Ghannoum, PhD, MBA, MS / Advisor / Case Western Reserve University, United States
  • Ferry Hagen / Advisor, Netherlands
  • Camille Hamula, PhD, D(ABMM) / Advisor / Saskatoon Health Region/University of Saskatchewan, Canada
  • Kimberly E. Hanson, MD, MHS / Advisor / University of Utah and ARUP Laboratories, United States
  • Nicole Holliday, BA / Advisor, United States
  • Scott B. Killian / Advisor / Thermo Fisher Scientific, United States
  • Laura Kovanda, BA,PhD / Advisor / Astellas Pharma Global Development, Inc., United States
  • Julianne Kus, HonBSc, MSc, PhD, FCCM / Member / Public Health Ontario, Canada
  • Sixto M. Leal Jr., MD, PhD / Advisor / University of Alabama at Birmingham, United States
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Member / Centers for Disease Control and Prevention, United States
  • Stephanie L. Mitchell, PhD, D(ABMM) / Member / Beckman Coulter, United States
  • Mary R. Motyl, PhD, D(ABMM) / Advisor / Merck & Company, Inc., United States
  • Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, CMQ / Advisor / Memorial Hermann Healthcare System - Houston, United States
  • Chris Pillar, PhD / Member / Microbiologics, United States
  • Gary W. Procop, MD, MS, MEd / Advisor / American Board of Pathology, United States
  • Jeffrey Rybak / Advisor, United States
  • Audrey N. Schuetz, MD, MPH, D(ABMM) / Advisor / Mayo Clinic Rochester, United States
  • Amir Seyedmousavi, VMD, PhD, D(ABMM), F(ECMM) / Member / National Institute of Health, United States
  • Ribhi M. Shawar, PhD, D(ABMM), F(AAM) / Advisor / FDA Center for Devices and Radiological Health, United States
  • Vera Tesic, MD, MS, D(ABMM) / Advisor / University of Chicago Medicine, United States
  • Priyanka Uprety, MSPH, PhD, D(ABMM) / Advisor / Quest Diagnostics, United States
  • Paul E. Verweij, MD, FECMM / Member / Radboud University Medical Center, Netherlands
  • Thomas J. Walsh, MD, PhD(hon), FIDSA, FAAM, FECMM / Advisor / Weill Cornell Medicine of Cornell University and New York Presbyterian Hospital, United States
  • Nathan P. Wiederhold, PharmD / Vice-Chairholder / University of Texas Health Science Center at San Antonio, United States
  • Adrian M Zelazny, PhD, D(ABMM) / Advisor / National Institutes of Health Department of Laboratory Medicine, United States
  • Sean X. Zhang, MD, PhD, D(ABMM) / Member / Johns Hopkins University, United States
  • Yanan (Nancy) Zhao, PhD, MD / Advisor / School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, United States

Subcommittee on Antifungal Susceptibility Tests (AFUNG)

  • Barbara D. Alexander, MD, MHS / Advisor / Duke University Medical Center, United States, Ended: Jan 1, 2024
  • Barbara D. Alexander, MD, MHS / Member / Duke University Medical Center, United States
  • David Andes, MD / Member / University of Wisconsin - Madison Medical School, United States
  • Marwan Mikheal Azar, MD / Advisor / Yale University, United States, Ended: Jan 1, 2024
  • Esther Babady, PhD, D(ABMM), FIDSA, F(AAM) / Advisor / Memorial Sloan Kettering Cancer Center, United States
  • Shukal Bala / Advisor / FDA CDER, United States
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Advisor / Centers for Disease Control and Prevention, United States
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Member / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Andrew M. Borman, BSc, PhD / Advisor / Public Health England, United Kingdom, Ended: Jan 1, 2024
  • Andrew M. Borman, BSc, PhD / Member / Public Health England, United Kingdom
  • Cecilia Carvalhaes / Advisor / bioMérieux, United States
  • Mariana Castanheira, PhD / Advisor / JMI Laboratories, United States, Ended: Jan 1, 2024
  • Sharon Chen / Advisor, United States
  • Anuradha Chowdhary, MD, PhD / Advisor / Vallabhbhai Patel Chest Institute, India
  • Sharon K. Cullen, BS, RAC / Advisor / Beckman Coulter, Inc. Microbiology Business, United States
  • Ryan Demkowicz, MD / Advisor / West Virginia University Hospital, United States, Ended: Dec 31, 2024
  • Tanis Dingle, PhD, D(ABMM), FCCM / Member / Alberta Precision Laboratories - Public Health Laboratory, Canada
  • Philippe J. Dufresne, PhD / Chairholder / Institut national de santé publique du Québec, Canada
  • Hari P. Dwivedi, BVSc(DVM), MVSc, PhD / Member / bioMerieux, Inc., United States
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Advisor / London Health Sciences Centre, Canada
  • Guillermo Garcia-Effron, BSc, PhD / Advisor / Universidad nacional del Litoral - Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Argentina
  • Mahmoud Ghannoum, PhD, MBA, MS / Advisor / Case Western Reserve University, United States
  • Kerian K. Grande Roche, PhD / Advisor / FDA Center for Drug Evaluation and Research, United States, Ended: Jan 1, 2024
  • Natasha Griffin, PhD / Advisor / MCRA, United States, Ended: Dec 31, 2024
  • Camille Hamula, PhD, D(ABMM) / Secretary / Saskatoon Health Region/University of Saskatchewan, Canada, Ended: Dec 31, 2024
  • Kimberly E. Hanson, MD, MHS / Advisor / University of Utah and ARUP Laboratories, United States
  • Nicole Holliday, BA / Advisor, United States
  • Scott B. Killian / Advisor / Thermo Fisher Scientific, United States
  • Laura Kovanda, BA,PhD / Advisor / Astellas Pharma Global Development, Inc., United States
  • Julianne Kus, HonBSc, MSc, PhD, FCCM / Advisor / Public Health Ontario, Canada, Ended: Dec 31, 2024
  • Sixto M. Leal Jr., MD, PhD / Advisor / University of Alabama at Birmingham, United States
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Member / Centers for Disease Control and Prevention, United States
  • Jacques F. Meis, MD, PhD, FIDSA, FRCPath, FAAM / Advisor / Canisius Wilhelmina Hospital, Netherlands, Ended: Jan 1, 2024
  • Stephanie L. Mitchell, PhD, D(ABMM) / Member / Beckman Coulter, United States
  • Mary R. Motyl, PhD, D(ABMM) / Advisor / Merck & Company, Inc., United States
  • Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, CMQ / Advisor / Memorial Hermann Healthcare System - Houston, United States
  • David S. Perlin, PhD / Advisor / Hackensack Meridian Health Center for Discovery and Innovation, United States, Ended: Jan 1, 2024
  • Chris Pillar, PhD / Member / Microbiologics, United States
  • Gary W. Procop, MD, MS, MEd / Advisor / American Board of Pathology, United States
  • Gary W. Procop, MD, MS, MEd / Vice-Chairholder / American Board of Pathology, United States, Ended: Jan 1, 2024
  • Jeffrey Rybak / Advisor, United States
  • Audrey N. Schuetz, MD, MPH, D(ABMM) / Member / Mayo Clinic Rochester, United States, Ended: Dec 31, 2024
  • Amir Seyedmousavi, VMD, PhD, D(ABMM), F(ECMM) / Member / National Institute of Health, United States
  • Ribhi M. Shawar, PhD, D(ABMM), F(AAM) / Advisor / FDA Center for Devices and Radiological Health, United States
  • Vera Tesic, MD, MS, D(ABMM) / Advisor / University of Chicago Medicine, United States
  • Priyanka Uprety, MSPH, PhD, D(ABMM) / Advisor / Quest Diagnostics, United States
  • Paul E. Verweij, MD, FECMM / Member / Radboud University Medical Center, Netherlands
  • Thomas J. Walsh, MD, PhD(hon), FIDSA, FAAM, FECMM / Advisor / Weill Cornell Medicine of Cornell University and New York Presbyterian Hospital, United States
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States, Ended: Jan 1, 2024
  • Nathan P. Wiederhold, PharmD / Vice-Chairholder / University of Texas Health Science Center at San Antonio, United States
  • Adrian M Zelazny, PhD, D(ABMM) / Advisor / National Institutes of Health Department of Laboratory Medicine, United States
  • Sean X. Zhang, MD, PhD, D(ABMM) / Member / Johns Hopkins University, United States
  • Sean X. Zhang, MD, PhD, D(ABMM) / Advisor / Johns Hopkins University, United States, Ended: Jan 1, 2024
  • Yanan (Nancy) Zhao, PhD, MD / Advisor / School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, United States

Subcommittee on Antifungal Susceptibility Tests (AFUNG)

  • Barbara D. Alexander, MD, MHS / Advisor / Duke University Medical Center, United States, Ended: Jan 1, 2024
  • David Andes, MD / Member / University of Wisconsin - Madison Medical School, United States
  • Marwan Mikheal Azar, MD / Advisor / Yale University, United States, Ended: Jan 1, 2024
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Member / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Andrew M. Borman, BSc, PhD / Advisor / Public Health England, United Kingdom, Ended: Jan 1, 2024
  • Mariana Castanheira, PhD / Advisor / JMI Laboratories, United States, Ended: Jan 1, 2024
  • Anuradha Chowdhary, MD, PhD / Advisor / Vallabhbhai Patel Chest Institute, India
  • Sharon K. Cullen, BS, RAC / Advisor / Beckman Coulter, Inc. Microbiology Business, United States
  • Ryan Demkowicz, MD / Advisor / West Virginia University Hospital, United States, Ended: Dec 31, 2024
  • Tanis Dingle, PhD, D(ABMM), FCCM / Member / Alberta Precision Laboratories - Public Health Laboratory, Canada
  • Philippe J. Dufresne, PhD / Chairholder / Institut national de santé publique du Québec, Canada
  • Philippe J. Dufresne, PhD / Vice-Chairholder / Institut national de santé publique du Québec, Canada, Ended: Jul 25, 2023
  • Hari P. Dwivedi, BVSc(DVM), MVSc, PhD / Member / bioMerieux, Inc., United States
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Advisor / London Health Sciences Centre, Canada
  • Mahmoud Ghannoum, PhD, MBA, MS / Advisor / Case Western Reserve University, United States
  • Kerian K. Grande Roche, PhD / Advisor / FDA Center for Drug Evaluation and Research, United States, Ended: Jan 1, 2024
  • Natasha Griffin, PhD / Advisor / MCRA, United States, Ended: Dec 31, 2024
  • Camille Hamula, PhD, D(ABMM) / Secretary / Saskatoon Health Region/University of Saskatchewan, Canada, Ended: Dec 31, 2024
  • Kimberly E. Hanson, MD, MHS / Advisor / University of Utah and ARUP Laboratories, United States
  • Nicole Holliday, BA / Advisor, United States
  • Laura Kovanda, BA,PhD / Advisor / Astellas Pharma Global Development, Inc., United States
  • Julianne Kus, HonBSc, MSc, PhD, FCCM / Advisor / Public Health Ontario, Canada, Ended: Dec 31, 2024
  • Sixto M. Leal Jr., MD, PhD / Advisor / University of Alabama at Birmingham, United States
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Jacques F. Meis, MD, PhD, FIDSA, FRCPath, FAAM / Advisor / Canisius Wilhelmina Hospital, Netherlands, Ended: Jan 1, 2024
  • Stephanie L. Mitchell, PhD, D(ABMM) / Member / Beckman Coulter, United States
  • Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, CMQ / Advisor / Memorial Hermann Healthcare System - Houston, United States
  • David S. Perlin, PhD / Advisor / Hackensack Meridian Health Center for Discovery and Innovation, United States, Ended: Jan 1, 2024
  • Gary W. Procop, MD, MS, MEd / Chairholder / American Board of Pathology, United States, Ended: Jul 25, 2023
  • Gary W. Procop, MD, MS, MEd / Vice-Chairholder / American Board of Pathology, United States, Ended: Jan 1, 2024
  • Audrey N. Schuetz, MD, MPH, D(ABMM) / Member / Mayo Clinic Rochester, United States, Ended: Dec 31, 2024
  • Amir Seyedmousavi, VMD, PhD, D(ABMM), F(ECMM) / Member / National Institute of Health, United States
  • Vera Tesic, MD, MS, D(ABMM) / Advisor / University of Chicago Medicine, United States
  • Paul E. Verweij, MD, FECMM / Member / Radboud University Medical Center, Netherlands
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States, Ended: Jan 1, 2024
  • Adrian M Zelazny, PhD, D(ABMM) / Advisor / National Institutes of Health Department of Laboratory Medicine, United States
  • Sean X. Zhang, MD, PhD, D(ABMM) / Advisor / Johns Hopkins University, United States, Ended: Jan 1, 2024

Subcommittee on Antifungal Susceptibility Tests (AFUNG)

  • Barbara D. Alexander, MD, MHS / Advisor / Duke University Medical Center, United States, Ended: Jan 1, 2024
  • David Andes, MD / Advisor / University of Wisconsin - Madison Medical School, United States, Ended: Dec 31, 2022
  • Marwan Mikheal Azar, MD / Advisor / Yale University, United States, Ended: Jan 1, 2024
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Member / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Andrew M. Borman, BSc, PhD / Advisor / Public Health England, United Kingdom, Ended: Jan 1, 2024
  • Mariana Castanheira, PhD / Advisor / JMI Laboratories, United States, Ended: Jan 1, 2024
  • Anuradha Chowdhary, MD, PhD / Advisor / Vallabhbhai Patel Chest Institute, India
  • Sharon K. Cullen, BS, RAC / Member / Beckman Coulter, Inc. Microbiology Business, United States, Ended: Dec 31, 2022
  • Tanis Dingle, PhD, D(ABMM), FCCM / Member / Alberta Precision Laboratories - Public Health Laboratory, Canada
  • Philippe J. Dufresne, PhD / Chairholder / Institut national de santé publique du Québec, Canada
  • Philippe J. Dufresne, PhD / Vice-Chairholder / Institut national de santé publique du Québec, Canada, Ended: Jul 25, 2023
  • Hari P. Dwivedi, BVSc(DVM), MVSc, PhD / Member / bioMerieux, Inc., United States
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Advisor / London Health Sciences Centre, Canada
  • Mahmoud Ghannoum, PhD, MBA, MS / Advisor / Case Western Reserve University, United States
  • Kerian K. Grande Roche, PhD / Advisor / FDA Center for Drug Evaluation and Research, United States, Ended: Jan 1, 2024
  • Camille Hamula, PhD, D(ABMM) / Advisor / Saskatoon Health Region/University of Saskatchewan, Canada, Ended: Dec 31, 2022
  • Kimberly E. Hanson, MD, MHS / Advisor / University of Utah and ARUP Laboratories, United States
  • Nicole Holliday, BA / Advisor, United States
  • Laura Kovanda, BA,PhD / Advisor / Astellas Pharma Global Development, Inc., United States
  • Julianne Kus, HonBSc, MSc, PhD, FCCM / Advisor / Public Health Ontario, Canada, Ended: Dec 31, 2024
  • Sixto M. Leal Jr., MD, PhD / Member / University of Alabama at Birmingham, United States, Ended: Dec 31, 2022
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Jacques F. Meis, MD, PhD, FIDSA, FRCPath, FAAM / Advisor / Canisius Wilhelmina Hospital, Netherlands, Ended: Jan 1, 2024
  • Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, CMQ / Advisor / Memorial Hermann Healthcare System - Houston, United States
  • David S. Perlin, PhD / Advisor / Hackensack Meridian Health Center for Discovery and Innovation, United States, Ended: Jan 1, 2024
  • Gary W. Procop, MD, MS, MEd / Chairholder / American Board of Pathology, United States, Ended: Jul 25, 2023
  • Gary W. Procop, MD, MS, MEd / Vice-Chairholder / American Board of Pathology, United States, Ended: Jan 1, 2024
  • Audrey N. Schuetz, MD, MPH, D(ABMM) / Member / Mayo Clinic Rochester, United States, Ended: Dec 31, 2024
  • Amir Seyedmousavi, VMD, PhD, D(ABMM), F(ECMM) / Member / National Institute of Health, United States
  • Ribhi M. Shawar, PhD, D(ABMM), F(AAM) / Advisor / FDA Center for Devices and Radiological Health, United States, Ended: Dec 31, 2022
  • Paul E. Verweij, MD, FECMM / Member / Radboud University Medical Center, Netherlands
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States, Ended: Jan 1, 2024
  • Adrian M Zelazny, PhD, D(ABMM) / Advisor / National Institutes of Health Department of Laboratory Medicine, United States
  • Sean X. Zhang, MD, PhD, D(ABMM) / Advisor / Johns Hopkins University, United States, Ended: Jan 1, 2024

Subcommittee on Antifungal Susceptibility Tests (AFUNG)

  • Barbara D. Alexander, MD, MHS / Advisor / Duke University Medical Center, United States, Ended: Jan 1, 2024
  • David Andes, MD / Advisor / University of Wisconsin - Madison Medical School, United States, Ended: Dec 31, 2022
  • Marwan Mikheal Azar, MD / Advisor / Yale University, United States, Ended: Jan 1, 2024
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Member / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Andrew M. Borman, BSc, PhD / Advisor / Public Health England, United Kingdom, Ended: Jan 1, 2024
  • Mariana Castanheira, PhD / Advisor / JMI Laboratories, United States, Ended: Jan 1, 2024
  • Jennifer Chau, PhD / Advisor / Beckman Coulter, Inc., United States, Ended: Dec 31, 2021
  • Sharon K. Cullen, BS, RAC / Member / Beckman Coulter, Inc. Microbiology Business, United States, Ended: Dec 31, 2022
  • Tanis Dingle, PhD, D(ABMM), FCCM / Advisor / Alberta Precision Laboratories - Public Health Laboratory, Canada, Ended: Dec 31, 2021
  • Philippe J. Dufresne, PhD / Vice-Chairholder / Institut national de santé publique du Québec, Canada, Ended: Jul 25, 2023
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Member / London Health Sciences Centre, Canada, Ended: Dec 31, 2021
  • Mahmoud Ghannoum, PhD, MBA, MS / Advisor / Case Western Reserve University, United States
  • Kerian K. Grande Roche, PhD / Advisor / FDA Center for Drug Evaluation and Research, United States, Ended: Jan 1, 2024
  • Camille Hamula, PhD, D(ABMM) / Advisor / Saskatoon Health Region/University of Saskatchewan, Canada, Ended: Dec 31, 2022
  • Kimberly E. Hanson, MD, MHS / Member / University of Utah and ARUP Laboratories, United States, Ended: Dec 31, 2021
  • Nicole Holliday, BA / Member, United States, Ended: Dec 31, 2021
  • Scott B. Killian / Advisor / Thermo Fisher Scientific, United States, Ended: Dec 31, 2021
  • Laura Kovanda, BA,PhD / Advisor / Astellas Pharma Global Development, Inc., United States
  • Sixto M. Leal Jr., MD, PhD / Advisor / University of Alabama at Birmingham, United States, Ended: Dec 31, 2021
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Jacques F. Meis, MD, PhD, FIDSA, FRCPath, FAAM / Advisor / Canisius Wilhelmina Hospital, Netherlands, Ended: Jan 1, 2024
  • Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, CMQ / Advisor / Memorial Hermann Healthcare System - Houston, United States
  • Laurence Pages-Monteiro, PharmD, PhD / Advisor / bioMerieux, France, Ended: Dec 31, 2021
  • David S. Perlin, PhD / Advisor / Hackensack Meridian Health Center for Discovery and Innovation, United States, Ended: Jan 1, 2024
  • Gary W. Procop, MD, MS, MEd / Chairholder / American Board of Pathology, United States, Ended: Jul 25, 2023
  • Audrey N. Schuetz, MD, MPH, D(ABMM) / Member / Mayo Clinic Rochester, United States, Ended: Dec 31, 2024
  • Amir Seyedmousavi, VMD, PhD, D(ABMM), F(ECMM) / Advisor / National Institute of Health, United States, Ended: Dec 31, 2021
  • Ribhi M. Shawar, PhD, D(ABMM), F(AAM) / Advisor / FDA Center for Devices and Radiological Health, United States, Ended: Dec 31, 2022
  • Paul E. Verweij, MD, FECMM / Member / Radboud University Medical Center, Netherlands
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States, Ended: Jan 1, 2024
  • Adrian M Zelazny, PhD, D(ABMM) / Member / National Institutes of Health Department of Laboratory Medicine, United States, Ended: Dec 31, 2021
  • Sean X. Zhang, MD, PhD, D(ABMM) / Advisor / Johns Hopkins University, United States, Ended: Jan 1, 2024

Subcommittee on Antifungal Susceptibility Tests (AFUNG)

  • Barbara D. Alexander, MD, MHS / Advisor / Duke University Medical Center, United States, Ended: Jan 1, 2024
  • David Andes, MD / Advisor / University of Wisconsin - Madison Medical School, United States, Ended: Dec 31, 2022
  • Marwan Mikheal Azar, MD / Advisor / Yale University, United States, Ended: Jan 1, 2024
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Member / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Mariana Castanheira, PhD / Advisor / JMI Laboratories, United States, Ended: Jan 1, 2024
  • Jennifer Chau, PhD / Advisor / Beckman Coulter, Inc., United States, Ended: Dec 31, 2021
  • Sharon C A Chen, PhD, FRACP, FRCPA / Advisor / Clinical Mycology Reference Laboratory, NSW Health Pathology, Westmead Hospital, Australia, Ended: Dec 31, 2020
  • Sharon K. Cullen, BS, RAC / Advisor / Beckman Coulter, Inc. Microbiology Business, United States, Ended: Dec 31, 2020
  • Tanis Dingle, PhD, D(ABMM), FCCM / Advisor / Alberta Precision Laboratories - Public Health Laboratory, Canada, Ended: Dec 31, 2021
  • Philippe J. Dufresne, PhD / Vice-Chairholder / Institut national de santé publique du Québec, Canada, Ended: Jul 25, 2023
  • Ana Espinel-Ingroff, PhD, MS / Advisor / Virginia Commonwealth University, United States, Ended: Dec 31, 2020
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Member / London Health Sciences Centre, Canada, Ended: Dec 31, 2021
  • Mahmoud Ghannoum, PhD, MBA, MS / Advisor / Case Western Reserve University, United States
  • Kerian K. Grande Roche, PhD / Advisor / FDA Center for Drug Evaluation and Research, United States, Ended: Jan 1, 2024
  • Camille Hamula, PhD, D(ABMM) / Advisor / Saskatoon Health Region/University of Saskatchewan, Canada, Ended: Dec 31, 2022
  • Kimberly E. Hanson, MD, MHS / Member / University of Utah and ARUP Laboratories, United States, Ended: Dec 31, 2021
  • Nicole Holliday, BA / Member, United States, Ended: Dec 31, 2021
  • Scott B. Killian / Advisor / Thermo Fisher Scientific, United States, Ended: Dec 31, 2021
  • Laura Kovanda, BA,PhD / Advisor / Astellas Pharma Global Development, Inc., United States
  • Sixto M. Leal Jr., MD, PhD / Advisor / University of Alabama at Birmingham, United States, Ended: Dec 31, 2021
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Jacques F. Meis, MD, PhD, FIDSA, FRCPath, FAAM / Advisor / Canisius Wilhelmina Hospital, Netherlands, Ended: Jan 1, 2024
  • Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, CMQ / Advisor / Memorial Hermann Healthcare System - Houston, United States
  • Anil A. Panackal, MD, SM, FACP, FIDSA, CTropMED / Advisor / Merck & Co., Inc, United States, Ended: Dec 4, 2020
  • David S. Perlin, PhD / Advisor / Hackensack Meridian Health Center for Discovery and Innovation, United States, Ended: Jan 1, 2024
  • David H. Pincus, MS, RM/SM(NRCM), SM(ASCP) / Member / bioMerieux, Inc., United States, Ended: Dec 31, 2020
  • Gary W. Procop, MD, MS, MEd / Chairholder / American Board of Pathology, United States, Ended: Jul 25, 2023
  • Audrey N. Schuetz, MD, MPH, D(ABMM) / Member / Mayo Clinic Rochester, United States, Ended: Dec 31, 2024
  • Ribhi M. Shawar, PhD, D(ABMM), F(AAM) / Advisor / FDA Center for Devices and Radiological Health, United States, Ended: Dec 31, 2022
  • Dee Shortridge, PhD / Advisor / JMI Laboratories, United States, Ended: Dec 31, 2020
  • Paul E. Verweij, MD, FECMM / Member / Radboud University Medical Center, Netherlands
  • Nancy L. Wengenack, PhD / Advisor / Mayo Clinic, United States, Ended: Dec 31, 2020
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States, Ended: Jan 1, 2024
  • Adrian M Zelazny, PhD, D(ABMM) / Member / National Institutes of Health Department of Laboratory Medicine, United States, Ended: Dec 31, 2021
  • Sean X. Zhang, MD, PhD, D(ABMM) / Advisor / Johns Hopkins University, United States, Ended: Jan 1, 2024

Subcommittee on Antifungal Susceptibility Tests (AFUNG)

  • Barbara D. Alexander, MD, MHS / Vice-Chairholder / Duke University Medical Center, United States, Ended: Dec 31, 2019
  • David Andes, MD / Advisor / University of Wisconsin - Madison Medical School, United States, Ended: Dec 31, 2022
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Dec 31, 2019
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Member / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Mariana Castanheira, PhD / Advisor / JMI Laboratories, United States, Ended: Jan 1, 2024
  • Jennifer Chau, PhD / Advisor / Beckman Coulter, Inc., United States, Ended: Dec 31, 2021
  • Sharon C A Chen, PhD, FRACP, FRCPA / Advisor / Clinical Mycology Reference Laboratory, NSW Health Pathology, Westmead Hospital, Australia, Ended: Dec 31, 2020
  • Sharon K. Cullen, BS, RAC / Advisor / Beckman Coulter, Inc. Microbiology Business, United States, Ended: Dec 31, 2020
  • Tanis Dingle, PhD, D(ABMM), FCCM / Advisor / Alberta Precision Laboratories - Public Health Laboratory, Canada, Ended: Dec 31, 2021
  • Philippe J. Dufresne, PhD / Member / Institut national de santé publique du Québec, Canada, Ended: Dec 31, 2019
  • Ana Espinel-Ingroff, PhD, MS / Advisor / Virginia Commonwealth University, United States, Ended: Dec 31, 2020
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Member / London Health Sciences Centre, Canada, Ended: Dec 31, 2021
  • Mahmoud Ghannoum, PhD, MBA, MS / Member / Case Western Reserve University, United States, Ended: Dec 31, 2019
  • Kerian K. Grande Roche, PhD / Advisor / FDA Center for Drug Evaluation and Research, United States, Ended: Jan 1, 2024
  • Camille Hamula, PhD, D(ABMM) / Advisor / Saskatoon Health Region/University of Saskatchewan, Canada, Ended: Dec 31, 2022
  • Kimberly E. Hanson, MD, MHS / Member / University of Utah and ARUP Laboratories, United States, Ended: Dec 31, 2021
  • Nicole Holliday, BA / Member, United States, Ended: Dec 31, 2021
  • Scott B. Killian / Advisor / Thermo Fisher Scientific, United States, Ended: Dec 31, 2021
  • Laura Kovanda, BA,PhD / Advisor / Astellas Pharma Global Development, Inc., United States, Ended: Dec 31, 2019
  • Frederic Lamoth, MD / Advisor / Centre Hospitalier Universitaire Vaudois, Switzerland, Ended: Dec 31, 2019
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Jacques F. Meis, MD, PhD, FIDSA, FRCPath, FAAM / Advisor / Canisius Wilhelmina Hospital, Netherlands, Ended: Jan 1, 2024
  • Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, CMQ / Member / Memorial Hermann Healthcare System - Houston, United States, Ended: Dec 31, 2019
  • Anil A. Panackal, MD, SM, FACP, FIDSA, CTropMED / Advisor / Merck & Co., Inc, United States, Ended: Dec 4, 2020
  • David S. Perlin, PhD / Advisor / Hackensack Meridian Health Center for Discovery and Innovation, United States, Ended: Jan 1, 2024
  • David H. Pincus, MS, RM/SM(NRCM), SM(ASCP) / Advisor / bioMerieux, Inc., United States, Ended: Dec 31, 2019
  • David H. Pincus, MS, RM/SM(NRCM), SM(ASCP) / Member / bioMerieux, Inc., United States, Ended: Dec 31, 2020
  • Gary W. Procop, MD, MS, MEd / Chairholder / American Board of Pathology, United States, Ended: Jul 25, 2023
  • Audrey N. Schuetz, MD, MPH, D(ABMM) / Member / Mayo Clinic Rochester, United States, Ended: Dec 31, 2024
  • Ribhi M. Shawar, PhD, D(ABMM), F(AAM) / Advisor / FDA Center for Devices and Radiological Health, United States, Ended: Dec 31, 2022
  • Ryan K. Shields, PhD, MS / Advisor / University of Pittsburgh Medical Center, United States, Ended: Dec 31, 2019
  • Dee Shortridge, PhD / Advisor / JMI Laboratories, United States, Ended: Dec 31, 2020
  • Paul E. Verweij, MD, FECMM / Advisor / Radboud University Medical Center, Netherlands, Ended: Dec 31, 2019
  • Nancy L. Wengenack, PhD / Advisor / Mayo Clinic, United States, Ended: Dec 31, 2020
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States, Ended: Jan 1, 2024
  • Adrian M Zelazny, PhD, D(ABMM) / Member / National Institutes of Health Department of Laboratory Medicine, United States, Ended: Dec 31, 2021
  • Sean X. Zhang, MD, PhD, D(ABMM) / Advisor / Johns Hopkins University, United States, Ended: Jan 1, 2024

Subcommittee on Antifungal Susceptibility Tests (AFUNG)

  • Barbara D. Alexander, MD, MHS / Vice-Chairholder / Duke University Medical Center, United States, Ended: Dec 31, 2019
  • David Andes, MD / Advisor / University of Wisconsin - Madison Medical School, United States, Ended: Dec 31, 2022
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Dec 31, 2019
  • Mariana Castanheira, PhD / Advisor / JMI Laboratories, United States, Ended: Jan 1, 2024
  • Jennifer Chau, PhD / Advisor / Beckman Coulter, Inc., United States, Ended: Dec 31, 2021
  • Sharon C A Chen, PhD, FRACP, FRCPA / Advisor / Clinical Mycology Reference Laboratory, NSW Health Pathology, Westmead Hospital, Australia, Ended: Dec 31, 2020
  • Sharon K. Cullen, BS, RAC / Advisor / Beckman Coulter, Inc. Microbiology Business, United States, Ended: Dec 31, 2020
  • Philippe J. Dufresne, PhD / Member / Institut national de santé publique du Québec, Canada, Ended: Dec 31, 2019
  • Ana Espinel-Ingroff, PhD, MS / Advisor / Virginia Commonwealth University, United States, Ended: Dec 31, 2020
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Member / London Health Sciences Centre, Canada, Ended: Dec 31, 2021
  • Mahmoud Ghannoum, PhD, MBA, MS / Member / Case Western Reserve University, United States, Ended: Dec 31, 2019
  • Kerian K. Grande Roche, PhD / Advisor / FDA Center for Drug Evaluation and Research, United States, Ended: Jan 1, 2024
  • Camille Hamula, PhD, D(ABMM) / Advisor / Saskatoon Health Region/University of Saskatchewan, Canada, Ended: Dec 31, 2022
  • Kimberly E. Hanson, MD, MHS / Member / University of Utah and ARUP Laboratories, United States, Ended: Dec 31, 2021
  • Denise Holliday, MT(ASCP) / Member / BD Diagnostic Systems, United States, Ended: Dec 31, 2018
  • Nicole Holliday, BA / Member, United States, Ended: Dec 31, 2021
  • Scott B. Killian / Advisor / Thermo Fisher Scientific, United States, Ended: Dec 31, 2021
  • Laura Kovanda, BA,PhD / Advisor / Astellas Pharma Global Development, Inc., United States, Ended: Dec 31, 2019
  • Raymond Kwong, PhD / Advisor / Beckman Coulter Diagnostic, MicroScan, United States, Ended: Aug 10, 2018
  • Frederic Lamoth, MD / Advisor / Centre Hospitalier Universitaire Vaudois, Switzerland, Ended: Dec 31, 2019
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Jacques F. Meis, MD, PhD, FIDSA, FRCPath, FAAM / Advisor / Canisius Wilhelmina Hospital, Netherlands, Ended: Jan 1, 2024
  • Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, CMQ / Member / Memorial Hermann Healthcare System - Houston, United States, Ended: Dec 31, 2019
  • Anil A. Panackal, MD, SM, FACP, FIDSA, CTropMED / Advisor / Merck & Co., Inc, United States, Ended: Dec 4, 2020
  • David S. Perlin, PhD / Advisor / Hackensack Meridian Health Center for Discovery and Innovation, United States, Ended: Jan 1, 2024
  • Gary W. Procop, MD, MS, MEd / Chairholder / American Board of Pathology, United States, Ended: Jul 25, 2023
  • Audrey N. Schuetz, MD, MPH, D(ABMM) / Member / Mayo Clinic Rochester, United States, Ended: Dec 31, 2024
  • Ribhi M. Shawar, PhD, D(ABMM), F(AAM) / Advisor / FDA Center for Devices and Radiological Health, United States, Ended: Dec 31, 2022
  • Ryan K. Shields, PhD, MS / Advisor / University of Pittsburgh Medical Center, United States, Ended: Dec 31, 2019
  • Dee Shortridge, PhD / Advisor / JMI Laboratories, United States, Ended: Dec 31, 2020
  • Nancy L. Wengenack, PhD / Advisor / Mayo Clinic, United States, Ended: Dec 31, 2020
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States, Ended: Jan 1, 2024
  • Adrian M Zelazny, PhD, D(ABMM) / Member / National Institutes of Health Department of Laboratory Medicine, United States, Ended: Dec 31, 2021
  • Sean X. Zhang, MD, PhD, D(ABMM) / Advisor / Johns Hopkins University, United States, Ended: Jan 1, 2024

Subcommittee on Antifungal Susceptibility Tests (AFUNG)

  • Barbara D. Alexander, MD, MHS / Chairholder / Duke University Medical Center, United States, Ended: Dec 31, 2017
  • David Andes, MD / Advisor / University of Wisconsin - Madison Medical School, United States, Ended: Dec 31, 2022
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Dec 31, 2019
  • Mariana Castanheira, PhD / Advisor / JMI Laboratories, United States, Ended: Jan 1, 2024
  • Jennifer Chau, PhD / Advisor / Beckman Coulter, Inc., United States, Ended: Dec 31, 2021
  • Sharon C A Chen, PhD, FRACP, FRCPA / Advisor / Clinical Mycology Reference Laboratory, NSW Health Pathology, Westmead Hospital, Australia, Ended: Dec 31, 2020
  • Sharon K. Cullen, BS, RAC / Advisor / Beckman Coulter, Inc. Microbiology Business, United States, Ended: Dec 31, 2020
  • Philippe J. Dufresne, PhD / Member / Institut national de santé publique du Québec, Canada, Ended: Dec 31, 2019
  • Ana Espinel-Ingroff, PhD, MS / Advisor / Virginia Commonwealth University, United States, Ended: Dec 31, 2020
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Member / London Health Sciences Centre, Canada, Ended: Dec 31, 2021
  • Mahmoud Ghannoum, PhD, MBA, MS / Member / Case Western Reserve University, United States, Ended: Dec 31, 2019
  • Kerian K. Grande Roche, PhD / Advisor / FDA Center for Drug Evaluation and Research, United States, Ended: Jan 1, 2024
  • Camille Hamula, PhD, D(ABMM) / Advisor / Saskatoon Health Region/University of Saskatchewan, Canada, Ended: Dec 31, 2022
  • Kimberly E. Hanson, MD, MHS / Member / University of Utah and ARUP Laboratories, United States, Ended: Dec 31, 2021
  • Denise Holliday, MT(ASCP) / Member / BD Diagnostic Systems, United States, Ended: Dec 31, 2018
  • Nicole Holliday, BA / Member, United States, Ended: Dec 31, 2021
  • Scott B. Killian / Advisor / Thermo Fisher Scientific, United States, Ended: Dec 31, 2021
  • Laura Kovanda, BA,PhD / Advisor / Astellas Pharma Global Development, Inc., United States, Ended: Dec 31, 2019
  • Raymond Kwong, PhD / Advisor / Beckman Coulter Diagnostic, MicroScan, United States, Ended: Aug 10, 2018
  • Frederic Lamoth, MD / Advisor / Centre Hospitalier Universitaire Vaudois, Switzerland, Ended: Dec 31, 2019
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Advisor / Centers for Disease Control and Prevention, United States, Ended: Jan 1, 2024
  • Jacques F. Meis, MD, PhD, FIDSA, FRCPath, FAAM / Advisor / Canisius Wilhelmina Hospital, Netherlands, Ended: Jan 1, 2024
  • Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, CMQ / Member / Memorial Hermann Healthcare System - Houston, United States, Ended: Dec 31, 2019
  • Anil A. Panackal, MD, SM, FACP, FIDSA, CTropMED / Advisor / Merck & Co., Inc, United States, Ended: Dec 4, 2020
  • David S. Perlin, PhD / Advisor / Hackensack Meridian Health Center for Discovery and Innovation, United States, Ended: Jan 1, 2024
  • Gary W. Procop, MD, MS, MEd / Vice-Chairholder / American Board of Pathology, United States, Ended: Dec 31, 2017
  • John H. Rex, MD / Advisor / F2G, United States, Ended: Dec 31, 2017
  • Audrey N. Schuetz, MD, MPH, D(ABMM) / Member / Mayo Clinic Rochester, United States, Ended: Dec 31, 2024
  • Ribhi M. Shawar, PhD, D(ABMM), F(AAM) / Advisor / FDA Center for Devices and Radiological Health, United States, Ended: Dec 31, 2022
  • Ryan K. Shields, PhD, MS / Advisor / University of Pittsburgh Medical Center, United States, Ended: Dec 31, 2019
  • Dee Shortridge, PhD / Advisor / JMI Laboratories, United States, Ended: Dec 31, 2020
  • Maria M. Traczewski, BS, MT(ASCP) / Advisor / The Clinical Microbiology Institute, United States, Ended: Dec 31, 2017
  • Paul E. Verweij, MD, FECMM / Advisor / Radboud University Medical Center, Netherlands, Ended: Dec 31, 2017
  • Nancy L. Wengenack, PhD / Advisor / Mayo Clinic, United States, Ended: Dec 31, 2020
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States, Ended: Jan 1, 2024
  • Peter R. Williamson, MD, PhD / Advisor / National Institutes of Health, Clinical Center, United States, Ended: Dec 31, 2017
  • Adrian M Zelazny, PhD, D(ABMM) / Member / National Institutes of Health Department of Laboratory Medicine, United States, Ended: Dec 31, 2021
  • Sean X. Zhang, MD, PhD, D(ABMM) / Advisor / Johns Hopkins University, United States, Ended: Jan 1, 2024

Subcommittee on Antifungal Susceptibility Tests (AFUNG)

  • Barbara D. Alexander, MD, MHS / Chairholder / Duke University Medical Center, United States, Ended: Dec 31, 2017
  • David Andes, MD / Advisor / University of Wisconsin - Madison Medical School, United States, Ended: Dec 31, 2022
  • Lynette Y. Berkeley, MLS(ASCP), PhD / Advisor / FDA Center for Drug Evaluation and Research, United States, Ended: Dec 31, 2016
  • Mariana Castanheira, PhD / Advisor / JMI Laboratories, United States, Ended: Jan 1, 2024
  • Sharon C A Chen, PhD, FRACP, FRCPA / Advisor / Clinical Mycology Reference Laboratory, NSW Health Pathology, Westmead Hospital, Australia, Ended: Dec 31, 2020
  • Sharon K. Cullen, BS, RAC / Member / Beckman Coulter, Inc. Microbiology Business, United States, Ended: Dec 31, 2016
  • Philippe J. Dufresne, PhD / Member / Institut national de santé publique du Québec, Canada, Ended: Dec 31, 2019
  • Ana Espinel-Ingroff, PhD, MS / Advisor / Virginia Commonwealth University, United States, Ended: Dec 31, 2020
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Member / London Health Sciences Centre, Canada, Ended: Dec 31, 2021
  • Mahmoud Ghannoum, PhD, MBA, MS / Member / Case Western Reserve University, United States, Ended: Dec 31, 2019
  • Kerian K. Grande Roche, PhD / Advisor / FDA Center for Drug Evaluation and Research, United States, Ended: Jan 1, 2024
  • Kimberly E. Hanson, MD, MHS / Member / University of Utah and ARUP Laboratories, United States, Ended: Dec 31, 2021
  • Nicole Holliday, BA / Advisor, United States, Ended: Dec 31, 2016
  • Lekeya Irby, CLS(MTA), MLS(ASCP) / Advisor / Kindred Hospital Rancho, United States, Ended: Dec 31, 2016
  • Cynthia C. Knapp, BS, MS, MT(ASCP) / Advisor / Thermo Fisher Scientific, United States, Ended: Dec 31, 2016
  • Laura Kovanda, BA,PhD / Advisor / Astellas Pharma Global Development, Inc., United States, Ended: Dec 31, 2019
  • Michael LaFleur, PhD / Advisor / Arietis, United States, Ended: Dec 31, 2016
  • Frederic Lamoth, MD / Advisor / Centre Hospitalier Universitaire Vaudois, Switzerland, Ended: Dec 31, 2019
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Member / Centers for Disease Control and Prevention, United States, Ended: Dec 31, 2016
  • Jacques F. Meis, MD, PhD, FIDSA, FRCPath, FAAM / Advisor / Canisius Wilhelmina Hospital, Netherlands, Ended: Jan 1, 2024
  • Luis Ostrosky-Zeichner, MD, FACP, FIDSA, FSHEA, CMQ / Member / Memorial Hermann Healthcare System - Houston, United States, Ended: Dec 31, 2019
  • David S. Perlin, PhD / Member / Hackensack Meridian Health Center for Discovery and Innovation, United States, Ended: Dec 31, 2016
  • Gary W. Procop, MD, MS, MEd / Vice-Chairholder / American Board of Pathology, United States, Ended: Dec 31, 2017
  • John H. Rex, MD / Advisor / F2G, United States, Ended: Dec 31, 2017
  • Ribhi M. Shawar, PhD, D(ABMM), F(AAM) / Advisor / FDA Center for Devices and Radiological Health, United States, Ended: Dec 31, 2022
  • Yvonne Shea, MS / Advisor / FDA Ctr. for Devices/Rad. Health (CDRH), United States, Ended: Dec 31, 2016
  • Ryan K. Shields, PhD, MS / Advisor / University of Pittsburgh Medical Center, United States, Ended: Dec 31, 2019
  • Dee Shortridge, PhD / Member / JMI Laboratories, United States, Ended: Dec 31, 2016
  • Maria M. Traczewski, BS, MT(ASCP) / Advisor / The Clinical Microbiology Institute, United States, Ended: Dec 31, 2017
  • Kenneth Van Horn / Advisor / Kenneth Van Horn, United States, Ended: Dec 31, 2016
  • Paul E. Verweij, MD, FECMM / Advisor / Radboud University Medical Center, Netherlands, Ended: Dec 31, 2017
  • Nancy L. Wengenack, PhD / Member / Mayo Clinic, United States, Ended: Dec 31, 2016
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States, Ended: Jan 1, 2024
  • Peter R. Williamson, MD, PhD / Advisor / National Institutes of Health, Clinical Center, United States, Ended: Dec 31, 2017
  • Sean X. Zhang, MD, PhD, D(ABMM) / Advisor / Johns Hopkins University, United States, Ended: Jan 1, 2024

Current Antifungal Subcommittee Working Groups

There are standing and ad hoc working groups devoted to supporting specific projects.

  • Tanis Dingle, PhD, D(ABMM), FCCM / Member / Alberta Precision Laboratories - Public Health Laboratory, Canada
  • Philippe J. Dufresne, PhD / Member / Institut national de santé publique du Québec, Canada
  • Kimberly E. Hanson, MD, MHS / Member / University of Utah and ARUP Laboratories, United States
  • Stephanie L. Mitchell, PhD, D(ABMM) / Member / Beckman Coulter, United States
  • Natasha N. Pettit, PharmD, BCIDP / Member / University of Chicago Medicine, United States
  • Audrey N. Schuetz, MD, MPH, D(ABMM) / Chairholder / Mayo Clinic Rochester, United States
  • Vera Tesic, MD, MS, D(ABMM) / Chairholder / University of Chicago Medicine, United States
  • Priyanka Uprety, MSPH, PhD, D(ABMM) / Member / Quest Diagnostics, United States
  • Thomas J. Walsh, MD, PhD(hon), FIDSA, FAAM, FECMM / Member / Weill Cornell Medicine of Cornell University and New York Presbyterian Hospital, United States
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States
  • Matthew A. Wikler, MD, FIDSA, MBA / Member / IDTD Consulting, United States
  • Yanan (Nancy) Zhao, PhD, MD / Member / School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, United States
  • David Andes, MD / Chairholder / University of Wisconsin - Madison Medical School, United States
  • Andrew M. Borman, BSc, PhD / Chairholder / Public Health England, United Kingdom
  • Mariana Castanheira, PhD / Member / JMI Laboratories, United States
  • Philippe J. Dufresne, PhD / Member / Institut national de santé publique du Québec, Canada
  • Kimberly E. Hanson, MD, MHS / Member / University of Utah and ARUP Laboratories, United States
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Member / Centers for Disease Control and Prevention, United States
  • Gary W. Procop, MD, MS, MEd / Member / American Board of Pathology, United States
  • Nathan P. Wiederhold, PharmD / Secretary / University of Texas Health Science Center at San Antonio, United States
  • Barbara D. Alexander, MD, MHS / Member / Duke University Medical Center, United States
  • Michael Birch, PhD / Advisor / Dr. Michael Birch, United Kingdom
  • Mariana Castanheira, PhD / Advisor / JMI Laboratories, United States
  • Philippe J. Dufresne, PhD / Vice-Chairholder / Institut national de santé publique du Québec, Canada
  • Jeff Fuller, PhD, FCCM, D(ABMM) / Member / London Health Sciences Centre, Canada
  • Mahmoud Ghannoum, PhD, MBA, MS / Member / Case Western Reserve University, United States
  • Kerian K. Grande Roche, PhD / Member / FDA Center for Drug Evaluation and Research, United States
  • Kimberly E. Hanson, MD, MHS / Member / University of Utah and ARUP Laboratories, United States
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Chairholder / Centers for Disease Control and Prevention, United States
  • Amir Seyedmousavi, VMD, PhD, D(ABMM), F(ECMM) / Member / National Institute of Health, United States
  • John D. Turnidge, MD, BS, FRACP, FASM, FRCPA / Member / The University of Adelaide, Australia
  • Thomas J. Walsh, MD, PhD(hon), FIDSA, FAAM, FECMM / Member / Weill Cornell Medicine of Cornell University and New York Presbyterian Hospital, United States
  • Nathan P. Wiederhold, PharmD / Secretary / University of Texas Health Science Center at San Antonio, United States
  • Elizabeth Berkow, PhD, D(ABMM), MLS(ASCP) / Advisor / Centers for Disease Control and Prevention, United States
  • Cecilia Carvalhaes / Member / bioMérieux, United States
  • Mariana Castanheira, PhD / Vice-Chairholder / JMI Laboratories, United States
  • Philippe J. Dufresne, PhD / Chairholder / Institut national de santé publique du Québec, Canada
  • Mahmoud Ghannoum, PhD, MBA, MS / Member / Case Western Reserve University, United States
  • Shawn R. Lockhart, PhD, D(ABMM), F(AAM) / Member / Centers for Disease Control and Prevention, United States
  • Nathan P. Wiederhold, PharmD / Member / University of Texas Health Science Center at San Antonio, United States
  • Sean X. Zhang, MD, PhD, D(ABMM) / Member / Johns Hopkins University, United States

Latest AST Insights

Get Involved

Share Your Expertise

Join our community of industry leaders who volunteer their experience and knowledge to drive innovation and excellence in laboratory practices.

Get Involved

Other Ways to Participate

Propose a Project

Anyone can propose a project. Suggestions are vetted by our Expert Panels and Consensus Council to prioritize new projects  for development. 

Propose a Project

Participate in the Process

Public review is an important part of the consensus process. Draft documents are shared with the general public for commenting and voting before being finalized for publication. 

Learn More

Become a Member

Join a global community committed to improving health outcomes through better laboratory practices. CLSI membership offers exclusive access to standards, professional development, and a voice in shaping the future of the field.

Explore Membership